Amgen Inc AMGN Posts 6 Q1 2026 Revenue Growth Balances Pipeline Progress With NearTerm Operational Headwinds How PPL PPLC performance reflects its true potential Trend Weakens 20260506 SACHA Sachem posts latest quarterly earnings with no available consensus estimate comparisons for core metrics WTF Waton revenue plummets 259 yearoveryear in Q2 shares steady despite wider loss SEBI Grants IPO Approval to Three Companies Late May 2026 Monte Rosa Therapeutics GLUE Q1 2026 Earnings EPS Miss Highlights Ongoing ClinicalStage Costs Stock Gains Modestly Soybean Futures Extend Rally as Supply Concerns and Strong Demand Drive Market Optimism